Star Wars Battlefront 3 has been on the minds of many fans, but creating this follow-up is not as simple as many believe. EA ...

The biotech raised $113 million in an institutional share placement last year to fund phase 3 development of sozinibercept, a VEGF 'trap' compound that targets two forms of the protein – VEGF-C ...